In particular, in a study conducted on 76 patients with IBD, the authors evidenced that in Crohn’s disease patients, the presence of 25 (OH) D < 30 ng/mL, in particular during the induction phase, was significantly related to early termination of anti-TNF therapy (14.5%) compared with normal levels of vitamin D (0%). This evidence concerns the gene TNF and Crohn disease.